ARTICLE | Clinical News
Nulojix belatacept regulatory update
February 18, 2013 8:00 AM UTC
Bristol-Myers and Germany's Statutory Health Insurance Funds Association (GKV-Spitzenverband) said they reached an agreement on the price for Nulojix belatacept to prevent organ rejection in adult kid...